You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北大醫藥(000788.SZ):頭孢米諾鈉注射液通過一致性評價
格隆匯 09-22 17:09

格隆匯9月22日丨北大醫藥(000788.SZ)公佈,近日,公司收到國家藥監局核准簽發的關於注射用頭孢米諾鈉(0.5g;1.0g)的《藥品補充申請批准通知書》。經審查,該藥品通過仿製藥質量和療效一致性評價。同時同意以下變更:1.變更直接接觸藥品的包裝材料和容器;2.變更藥品質量標準;3.修訂藥品説明書。

頭孢米諾鈉為半合成的第二代頭孢菌素,對革蘭陽性菌和陰性菌都有強大抗菌活性,屬於廣譜抗菌,特別是對大腸桿菌、克雷伯桿菌、變形桿菌、流感桿菌、擬桿菌及鏈球菌具較強抗菌活性。臨牀主要用於敏感菌所致的呼吸道感染、泌尿道感染、膽道感染、腹腔感染、子宮感染等,也可用於敗血症。

公司的頭孢米諾鈉注射液通過仿製藥質量和療效一致性評價,不僅為公司後續一致性評價產品研究再次積累了寶貴經驗,對公司研發能力的提升具有積極意義,更進一步完善了公司在抗感染領域的產品結構,有利於提升公司在抗感染治療領域產品市場的競爭力,對公司未來業績的提升有積極作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account